Remove Blogging Remove Layoffs Remove Product Remove San Diego
article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.

article thumbnail

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. —San Antonio, TX-based StemBioSys inked its second distribution deal in as many months, announcing plans to bring its stem cell production products to South Korea.

News 40
article thumbnail

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

—The FDA approved a cholera vaccine , Vaxchora, giving Redwood City, CA-based PaxVax its second commercial product. . —Shares of Boston-based Paratek Pharmaceuticals (NASDAQ: PRTK ), meanwhile, surged more than 20 percent after its antibiotic, omadacycline, succeeded in the first of two Phase 3 trials. right now.

News 55